63 results
424B3
KPRX
Kiora Pharmaceuticals Inc
28 Mar 24
Prospectus supplement
4:48pm
and restated bylaws provide that a special meeting of stockholders may be called only by our chairman of the board or chief executive officer
8-K
KPRX
Kiora Pharmaceuticals Inc
27 Sep 23
Submission of Matters to a Vote of Security Holders
7:06pm
Holders.
On September 27, 2023, Kiora Pharmaceuticals, Inc. (the “Company”) held a Special Meeting of Stockholders (the “Special Meeting … ”). At the Special Meeting, the Company’s stockholders voted on the following proposals:
(i) the approval of an amendment to the Company’s 2014 Equity Incentive Plan
8-K
EX-99.1
98gspvec23qd
21 Sep 23
Kiora Pharmaceuticals Appoints Praveen Tyle, PhD, as New Chairman; Succeeds Paul Chaney Who is Retiring After Serving 17 Years
7:00am
DEFA14A
EX-99.1
o1hl0qff 6e
1 Sep 23
Additional proxy soliciting materials
7:00am
DEFA14A
484u6171wtau0dyo7toq
1 Sep 23
Additional proxy soliciting materials
7:00am
8-K
qji23z21d wq
1 Sep 23
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
7:00am
8-K
EX-99.1
5kfflgjlnhfa6oa0ng
1 Sep 23
Kiora Pharmaceuticals Adjourns Special Meeting of Stockholders to September 27
7:00am
424B1
9qyguj8qtphw6fzh
2 Jun 23
Prospectus with pricing info
5:08pm
424B3
a1o583 03buqmaf
28 Dec 22
Prospectus supplement
4:48pm
8-K
adcz5sgr1rxqwrr
16 Sep 22
Kiora Pharmaceuticals Appoints Melissa Tosca as Executive Vice President of Finance
4:30pm